New YorkRequires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic
What it does
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- May 29REFERRED TO HEALTHLatest
- Vote recorded Floor Vote - Version: B. Result: pass.Upper
- May 29DELIVERED TO ASSEMBLY
- May 29PASSED SENATEPassed 1st Chamber
- May 14ADVANCED TO THIRD READING
- May 132ND REPORT CAL.
- May 121ST REPORT CAL.1095
- Vote recorded Health Vote - Version: B. Result: pass.Upper
- May 5PRINT NUMBER 6758BMajor
- May 5AMEND AND RECOMMIT TO HEALTHMajor
- Jan 16PRINT NUMBER 6758AMajor
- Jan 16AMEND AND RECOMMIT TO HEALTHMajor
- Jan 7REFERRED TO HEALTHMinor
- May 29REFERRED TO HEALTHLatest
- 2025
- Mar 24REFERRED TO HEALTHIntroduced